Allicin rapidly breaks down to form a variety of organosulfur compounds
Serious injuries and symptoms discussed in Wegovy and GLP-1 litigation may include: Gastroparesis or delayed gastric emptying Stomach paralysis symptoms, including nausea, vomiting, bloating, abdominal pain, early fullness, and difficulty keeping food down Ileus or intestinal blockage Bowel obstruction or pseudo-obstruction Persistent vomiting and dehydration Malnutrition or inability to tolerate normal food intake Severe abdominal pain requiring emergency care or hospitalization Pancreatitis, which has been reported as a risk signal in GLP-1 research NAION-related vision loss, which should be evaluated separately from gastrointestinal injury claims These allegations do not mean every patient who used Wegovy has a claim
The longer the food stays in your stomach, the less hungry you are and the less you eat
Community sources describe this as the most common failure mode for ultra-low-cost marketplace listings the ones priced at $3-5 per 30 mL vial, well below the cost floor for USP-compliant product
Bonatis success with conscious IV sedation, some other surgeons around the country have adopted that technique
the latter explanation is suggested by our results (see Fig